Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
KalVista Pharma (KALV) Forecast
NewsEarningsKalVista Pharma (KALV) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
KalVista Pharma Stock Price, Quotes and Forecasts | NASDAQ:KALV | Benzinga
Explore KalVista Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KALV.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ:KALV) through any online brokerage.
Who are KalVista Pharma (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Immunome (NASDAQ:IMNM), Valneva (NASDAQ:VALN), Precigen (NASDAQ:PGEN), Prothena Corp (NASDAQ:PRTA) and Immatics (NASDAQ:IMTX).
What is the forecast, or price target, for KalVista Pharma (KALV) stock?
KalVista Pharma has a consensus price target of $25.00.
What is the current price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $12.28 last updated March 25, 2025 at 2:14 PM EDT.
Does KalVista Pharma (KALV) pay a dividend?
There are no upcoming dividends for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q3 earnings are confirmed for Wednesday, March 12, 2025.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.